SONOMA PHARMACEUTICALS INC (SNOA)
US83558L2043 - Common Stock
| TTM (2023-12-31) | 2023 (2023-3-31) | 2022 (2022-3-31) | 2021 (2021-3-31) | 2020 (2020-3-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -5.08M | -5.15M | -5.09M | -3.95M | -2.95M | |||
| Depreciation Amortization | 175.00K | 130.00K | 190.00K | 230.00K | 310.00K | |||
| Income Taxes - Deferred | 292.00K | -40.00K | -830.00K | N/A | N/A | |||
| Change In Working Capital | -866.00K | -1.69M | 3.35M | 1.38M | -1.56M | |||
| Interest Paid | 25.00K | 20.00K | 20.00K | 10.00K | 20.00K | |||
| Taxes Paid | N/A | 0.00 | 770.00K | 940.00K | N/A | |||
| Other non cash items | 477.00K | 600.00K | -1.87M | -1.04M | -400.00K | |||
| OPERATING CASH FLOW | -4.99M | -6.15M | -4.25M | -3.38M | -4.59M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -210.00K | -270.00K | -140.00K | -180.00K | -210.00K | |||
| Other Investing Activity | N/A | 10.00K | 40.00K | 570.00K | 3.85M | |||
| INVESTING CASH FLOW | -100.00K | -260.00K | -100.00K | 390.00K | 3.64M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 23.00K | -380.00K | -370.00K | 1.02M | -350.00K | |||
| Stock Issued/Repurchased | N/A | 2.87M | 7.77M | 2.29M | 1.38M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 4.42M | 2.49M | 7.40M | 3.31M | 1.03M | |||
| Exchange Rate Effect | 442.00K | 350.00K | 130.00K | 210.00K | -80.00K | |||
| CHANGE IN CASH | -224.00K | -3.57M | 3.18M | 530.00K | 0.00 | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -4.99M | -6.15M | -4.25M | -3.38M | -4.59M | |||
| Capital Expenditure | -210.00K | -270.00K | -140.00K | -180.00K | -210.00K | |||
| FREE CASH FLOW | -5.20M | -6.42M | -4.39M | -3.56M | -4.80M | |||
All data in USD